Headline from Dow Jones News Wire - "Mayne Pharma Price Target Cut 13% to A$1.63/Share by Bell Potter"
I always felt Bell Potter were a little too bullish on MYX, targeting $1.80, but it's good to read them come back because it validates my personal target, which remains $1.60 - and I'll continue accumulating up to $1.40 (depending on my personal cash flow and balance of my portfolio). This has to be the best bargain on the ASX currently.
We just need a decent reporting season (after I've acquired about a half-billion shares)
Once again, though, those shorters are hitting us insanely hard, so avoid MYX (or be really careful about risk) if you're trading on margin.
Bell Potter downgrades target to $1.63
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.71 |
Change
0.070(1.51%) |
Mkt cap ! $400.7M | |||
| Open | High | Low | Value | Volume |
| $4.67 | $4.75 | $4.62 | $953.1K | 203.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1236 | $4.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.72 | 620 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MYX (ASX) Chart |